Congestive heart failure with preserved EF pharmacotherapy: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

19 August 2022

22 June 2022

  • curprev 20:5620:56, 22 June 2022‎ Edzelco talk contribs‎ 37,729 bytes +957‎ No edit summary
  • curprev 20:2420:24, 22 June 2022‎ Edzelco talk contribs‎ 36,772 bytes +12‎ No edit summary
  • curprev 20:2320:23, 22 June 2022‎ Edzelco talk contribs‎ 36,760 bytes −92‎ /* 2022 AHA/ACC/HFSA Heart Failure Guideline (DO NOT EDIT) {{cite journal| author=Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM | display-authors=etal| title=2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=Circulation | year= 2022 | volume= 145 | issue= 18 | pages= e876-e894 | pmid=35363500 | doi=10.1161/C...
  • curprev 20:2320:23, 22 June 2022‎ Edzelco talk contribs‎ 36,852 bytes −5‎ →‎Heart Failure With Mildly Reduced EF (HFmrEF) and Improved EF (HFimpHF)
  • curprev 20:2320:23, 22 June 2022‎ Edzelco talk contribs‎ 36,857 bytes +1,377‎ →‎Heart failure mildly reduced ejection fraction (HPmrEF), EF (41-49%)
  • curprev 20:2220:22, 22 June 2022‎ Edzelco talk contribs‎ 35,480 bytes −1,366‎ /* 2022 AHA/ACC/HFSA Heart Failure Guideline (DO NOT EDIT) {{cite journal| author=Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM | display-authors=etal| title=2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=Circulation | year= 2022 | volume= 145 | issue= 18 | pages= e876-e894 | pmid=35363500 | doi=10.1161/C...
  • curprev 20:2220:22, 22 June 2022‎ Edzelco talk contribs‎ 36,846 bytes 0‎ →‎Heart failure mildly reduced ejection fraction (HPmrEF), EF (41-49%)
  • curprev 20:2020:20, 22 June 2022‎ Edzelco talk contribs‎ 36,846 bytes +9,169‎ →‎Heart failure mildly reduced ejection fraction (HPmrEF), EF (41-49%)
  • curprev 20:1820:18, 22 June 2022‎ Edzelco talk contribs‎ 27,677 bytes +1‎ No edit summary
  • curprev 20:1820:18, 22 June 2022‎ Edzelco talk contribs‎ 27,676 bytes +2‎ →‎Heart failure mildly reduced ejection fraction (HPmrEF), EF (41-49%)
  • curprev 20:1720:17, 22 June 2022‎ Edzelco talk contribs‎ 27,674 bytes +4‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
  • curprev 20:1720:17, 22 June 2022‎ Edzelco talk contribs‎ 27,670 bytes +2‎ →‎Heart failure preserved ejection fraction (HFpEF)
  • curprev 20:1620:16, 22 June 2022‎ Edzelco talk contribs‎ 27,668 bytes −2‎ /* 2022 AHA/ACC/HFSA Heart Failure Guideline (DO NOT EDIT) {{cite journal| author=Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM | display-authors=etal| title=2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=Circulation | year= 2022 | volume= 145 | issue= 18 | pages= e876-e894 | pmid=35363500 | doi=10.1161/C...
  • curprev 20:1620:16, 22 June 2022‎ Edzelco talk contribs‎ 27,670 bytes +1‎ /* 2022 AHA/ACC/HFSA Heart Failure Guideline (DO NOT EDIT) {{cite journal| author=Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM | display-authors=etal| title=2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=Circulation | year= 2022 | volume= 145 | issue= 18 | pages= e876-e894 | pmid=35363500 | doi=10.1161/C...
  • curprev 20:1520:15, 22 June 2022‎ Edzelco talk contribs‎ 27,669 bytes +6‎ /* 2022 AHA/ACC/HFSA Heart Failure Guideline (DO NOT EDIT) {{cite journal| author=Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM | display-authors=etal| title=2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. | journal=Circulation | year= 2022 | volume= 145 | issue= 18 | pages= e876-e894 | pmid=35363500 | doi=10.1161/C...
  • curprev 20:1520:15, 22 June 2022‎ Edzelco talk contribs‎ 27,663 bytes +2‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
  • curprev 20:1420:14, 22 June 2022‎ Edzelco talk contribs‎ 27,661 bytes +1‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
  • curprev 20:1420:14, 22 June 2022‎ Edzelco talk contribs‎ 27,660 bytes +1‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
  • curprev 20:1420:14, 22 June 2022‎ Edzelco talk contribs‎ 27,659 bytes −54‎ →‎Medications indicated in patients with New York Heart Association (NYHA class II–IV) HFmrEF (heart failure with mildly reduced ejection fraction) (LVEF41-49%)
  • curprev 20:1220:12, 22 June 2022‎ Edzelco talk contribs‎ 27,713 bytes 0‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
  • curprev 20:1220:12, 22 June 2022‎ Edzelco talk contribs‎ 27,713 bytes 0‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
  • curprev 20:1120:11, 22 June 2022‎ Edzelco talk contribs‎ 27,713 bytes +1‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
  • curprev 20:1120:11, 22 June 2022‎ Edzelco talk contribs‎ 27,712 bytes 0‎ →‎Medications indicated in patients with New York Heart Association (NYHA class II–IV) HFmrEF (heart failure with mildly reduced ejection fraction) (LVEF41-49%)
  • curprev 20:1120:11, 22 June 2022‎ Edzelco talk contribs‎ 27,712 bytes 0‎ /* 2021 European Society of Cardiology Guidelines (DO NOT EDIT) {{cite journal |vauthors=McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A |title=2021 ESC Guidelines for the d...
(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://www.wikidoc.org/index.php/Congestive_heart_failure_with_preserved_EF_pharmacotherapy"